☆ 4.8 Editorial Material

TRPV1: a new target for treatment of visceral pain in IBS?

GUT (2008)

Journal

GUT

Volume 57, Issue 7, Pages 882-884

Publisher

B M J PUBLISHING GROUP

DOI: 10.1136/gut.2008.149724

Keywords

-

Categories

Gastroenterology & Hepatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Integrative & Complementary Medicine

P2Y12 receptor as a new target for electroacupuncture relieving comorbidity of visceral pain and depression of inflammatory bowel disease

Yanzhen Li, Hong Zhang, Jingwen Yang, Muouyang Zhan, Xuefei Hu, Yongmin Liu, Lingling Yu, Xiaochen Yan, Shangdong Liang, Ruyue Zhang, Ying Lu, Beining Li, Cunzhi Liu, Man Li

Summary: The study found that increased expression of P2Y12 in the mPFC is associated with visceral pain and depression in IBD mice, and interfering with P2Y12 expression in the mPFC or performing EA treatment can significantly alleviate visceral pain and depression in IBD mice. EA treatment can also downregulate P2Y12 expression, weaken microglial activation, and inhibit IL-1 beta expression in the mPFC, thereby relieving visceral pain and depression in IBD mice.

CHINESE MEDICINE (2021)

Add to Collection

Review Gastroenterology & Hepatology

Review article: current and future treatment approaches for pain in IBS

Peter Paine

Summary: Abdominal pain is a core symptom of IBS, with visceral hypersensitivity being a key pathophysiological mechanism. Treatments for IBS pain include non-pharmacological approaches such as diet modifications, probiotics, and psychological interventions, as well as pharmacological options like tricyclics and newer medications. Emerging treatment options include gut-brain neuromodulators, neurostimulation, and novel psychological approaches.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)

Add to Collection

Article Gastroenterology & Hepatology

Gut-innervating TRPV1+ Neurons Drive Chronic Visceral Pain via Microglial P2Y12 Receptor

Manon Defaye, Nasser S. Abdullah, Mircea Iftinca, Ahmed Hassan, Francina Agosti, Zizhen Zhang, Melissa Cumenal, Gerald W. Zamponi, Christophe Altier

Summary: The research explores the mechanisms of chronic abdominal pain in IBD patients, focusing on the role of neuronal activity in microglial activation and visceral hypersensitivity. It suggests that targeting microglial P2Y12 signaling could potentially alleviate pain in patients in remission.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

Effect of resolvins on sensitisation of TRPV1 and visceral hypersensitivity in IBS

Eluisa Perna, Javier Aguilera-Lizarraga, Morgane Florens, Piyush Jain, Stavroula A. Theofanous, Nikita Hanning, Joris G. De Man, Maya Berg, Benedicte De Winter, Yeranddy A. Alpizar, Karel Talavera, Pieter Vanden Berghe, Mira Wouters, Guy Boeckxstaens

Summary: Objective Resolvins, particularly RvD2, have shown promising effects in reducing TRPV1 sensitisation in murine and rat models, suggesting their potential as novel treatment options for IBS. Additionally, RvD2 has been found to decrease the response of submucosal neurons in rectal biopsies of IBS patients to capsaicin.

GUT (2021)

Add to Collection

Article Pharmacology & Pharmacy

Intracolonic Mustard Oil Induces Visceral Pain in Mice by TRPA1-Dependent and -Independent Mechanisms: Role of Tissue Injury and P2X Receptors

Rafael Gonzalez-Cano, Angeles Montilla-Garcia, Gloria Perazzoli, Jesus M. Torres, Francisco J. Canizares, Eduardo Fernandez-Segura, Michael Costigan, Jose M. Baeyens, Enrique J. Cobos

Summary: Both TRPA1 and purinergic P2X receptors are proposed as potential targets for the treatment of visceral pain. While a low dose of mustard oil induces visceral pain dependent on TRPA1, a higher dose results in pain mostly independent of TRPA1 but enhanced by ATP released from damaged tissues. Thus, TRPA1 inhibition may not be sufficient to decrease visceral pain significantly during tissue injury, and purinergic antagonism appears to be a more effective strategy.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Double-blinded randomised placebo controlled trial of enterosgel (polymethylsiloxane polyhydrate) for the treatment of IBS with diarrhoea (IBS-D)

Carol Angela Howell, Anu Kemppinen, Victoria Allgar, Matthew Dodd, Charles H. Knowles, John McLaughlin, Preeti Pandya, Peter Whorwell, Elena Markaryan, Yan Yiannakou

Summary: This study demonstrates that Enterosgel is safe and effective in patients with IBS-D, improving stool consistency, abdominal pain, stool frequency, and urgency. This provides an alternative to the limited current treatment options.

GUT (2022)

Add to Collection

Review Food Science & Technology

Tetrodotoxin: A New Strategy to Treat Visceral Pain?

Ana Campos-Rios, Lola Rueda-Ruzafa, Salvador Herrera-Perez, Paula Rivas-Ramirez, Jose Antonio Lamas

Summary: Visceral pain is a common symptom in functional gastrointestinal disorders, with the involvement of both the central and peripheral nervous systems in visceral hypersensitivity. Current treatments often involve opioids, but their side effects and decreasing effectiveness have led to a search for new therapies, with tetrodotoxin being a promising option.

TOXINS (2021)

Add to Collection

Review Gastroenterology & Hepatology

Review article: current and future treatment approaches for IBS with constipation

Joy J. Liu, Darren M. Brenner

Summary: This article reviews clinical trial efficacy data and survey data on several treatments for IBS-C, emphasizing the importance of standardizing quality of life and symptom metrics in future trials and tailoring treatment selection based on symptom improvement probability, safety, tolerability, and cost.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)

Add to Collection

Review Chemistry, Medicinal

The Importance of Visceral Hypersensitivity in Irritable Bowel Syndrome-Plant Metabolites in IBS Treatment

Ewa Dudzinska, Andreas M. Grabrucker, Pawel Kwiatkowski, Robert Sitarz, Monika Sienkiewicz

Summary: Visceral stimuli from the digestive tract are transmitted to the brain via nerves, causing overreaction in the brain of irritable bowel syndrome (IBS) patients. Stress and dysbiosis can lead to inflammation and gastrointestinal hypersensitivity. Treating IBS involves reducing visceral hypersensitivity and regulating the intestinal microbiota.

PHARMACEUTICALS (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Phoenixin as a New Target in the Development of Strategies for Endometriosis Diagnosis and Treatment

Karolina Iwona Kulinska, Miroslaw Andrusiewicz, Anna Dera-Szymanowska, Maria Billert, Marek Skrzypski, Krzysztof Szymanowski, Ewa Nowak-Markwitz, Malgorzata Kotwicka, Maria Wolun-Cholewa

Summary: The study found that patients with endometriosis have reduced PNX levels, increased LH/FSH ratio, and elevated 17β-estradiol concentration. GPR173 expression was lower in ectopic endometrium. These findings provide new insights into the pathophysiology and diagnosis and treatment strategies for endometriosis.

BIOMEDICINES (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Ghrelin polymorphism/TRPV1 receptor expression in Egyptian IBS patients

Walaa Samy, Ahmed El Gebaly, Nabila H. Ahmed, Aliaa Talaat

Summary: This study found an association between ghrelin gene polymorphism and irritable bowel syndrome (IBS), with the GG genotype of rs696217 occurring more frequently in patients. This genotype was associated with a significant decrease in ghrelin mRNA expression and a subsequent increase in TRPV1 gene expression, which may explain some of the manifestations of IBS.

CYTOKINE (2022)

Add to Collection

Article Biochemistry & Molecular Biology

TRPV1 Responses in the Cerebellum Lobules VI, VII, VIII Using Electroacupuncture Treatment for Chronic Pain and Depression Comorbidity in a Murine Model

Bernice Lottering, Yi-Wen Lin

Summary: Depression often coexists with chronic pain, leading to poor prognosis. Electroacupuncture has shown success in pain treatment, with research indicating changes in cerebellum lobules VI, VII, VIII, which are alleviated through its action on TRPV1 and related molecular pathways.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Pharmacology & Pharmacy

Emetic Tartar-Loaded Liposomes as a New Strategy for Leishmaniasis Treatment

Larissa D. Coelho, Mirna M. D. Souza, Geovanni D. Cassali, Raphaela A. Silva, Maria J. N. Paiva, Andre L. B. Barros, Eliane M. Teixeira, Josianne N. Silveira, Paulo M. Z. Coelho, Marta M. G. Aguiar, Monica C. Oliveira

Summary: Liposomes containing emetic tartar (ET) were prepared and evaluated for the treatment of leishmaniasis. The encapsulation of ET in liposomes reduced its side effects and showed antileishmanial activity in a mouse model.

PHARMACEUTICS (2023)

Add to Collection

Article Orthopedics

Exposure in Vivo as a Treatment Approach to Target Pain-Related Fear: Theory and New Insights From Research and Clinical Practice

Marlies den Hollander, Rob J. E. M. Smeets, Thijs van Meulenbroek, Charlotte C. M. van Laake-Geelen, Vera A. Baadjou, Inge Timmers

Summary: This Perspective discusses the contribution of pain-related fear (PRF) to pain-related disability in individuals with persistent pain and proposes exposure in vivo (EXP) as a treatment approach. The paper summarizes recent theoretical advancements, provides suggestions for optimizing inhibitory learning during EXP, reviews neuroimaging studies supporting the targeting of PRF in people with chronic pain, and focuses on the clinical applications of EXP for PRF. It also highlights the evolving directions of EXP, such as its use in chronic secondary pain and in primary care with physical therapists playing a crucial role.

PHYSICAL THERAPY (2022)

Add to Collection

Review Pharmacology & Pharmacy

TRPV1: A promising therapeutic target for skin aging and inflammatory skin diseases

Tengfei Xiao, Mingzhong Sun, Chuanxiang Zhao, Jingjing Kang

Summary: TRPV1 is a widely expressed non-selective channel receptor in skin tissues, including keratinocytes, peripheral sensory nerve fibers, and immune cells. It is activated by various inflammatory mediators, leading to neuropeptide release and neurogenic inflammatory response. Previous studies have indicated that TRPV1 is closely associated with skin aging and chronic inflammatory skin diseases such as psoriasis, atopic dermatitis, rosacea, herpes zoster, allergic contact dermatitis, and prurigo nodularis.

FRONTIERS IN PHARMACOLOGY (2023)

Add to Collection

Article Nutrition & Dietetics

Influence of 4-week multi-strain probiotic administration on resting-state functional connectivity in healthy volunteers

Deepika Bagga, Christoph Stefan Aigner, Johanna Louise Reichert, Cinzia Cecchetto, Florian Ph S. Fischmeister, Peter Holzer, Christine Moissl-Eichinger, Veronika Schoepf

EUROPEAN JOURNAL OF NUTRITION (2019)

Add to Collection

Article Neurosciences

High-fat diet induces depression-like behaviour in mice associated with changes in microbiome, neuropeptide Y, and brain metabolome

Ahmed M. Hassan, Giulia Mancano, Karl Kashofer, Esther E. Froehlich, Andrija Matak, Raphaela Mayerhofer, Florian Reichmann, Marta Olivares, Audrey M. Neyrinck, Nathalie M. Delzenne, Sandrine P. Claus, Peter Holzer

NUTRITIONAL NEUROSCIENCE (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Diabesity and mood disorders: Multiple links through the microbiota-gut-brain axis

Aitak Farzi, Ahmed M. Hassan, Geraldine Zenz, Peter Holzer

MOLECULAR ASPECTS OF MEDICINE (2019)

Add to Collection

Article Endocrinology & Metabolism

Epigenetics of the molecular clock and bacterial diversity in bipolar disorder

S. A. Bengesser, S. Moerkl, A. Painold, N. Dalkner, A. Birner, F. T. Fellendorf, M. Platzer, R. Queissner, C. Hamm, A. Maget, R. Pilz, A. Rieger, J. Wagner-Skacel, B. Reininghaus, H. P. Kapfhammer, E. Petek, K. Kashofer, B. Halwachs, P. Holzer, A. Waha, E. Z. Reininghaus

PSYCHONEUROENDOCRINOLOGY (2019)

Add to Collection

Article Nutrition & Dietetics

Synergistic and antagonistic interactions between antibiotics and synbiotics in modifying the murine fecal microbiome

Angela Jacan, Karl Kashofer, Geraldine Zenz, Esther E. Froehlich, Florian Reichmann, Ahmed M. Hassan, Peter Holzer

EUROPEAN JOURNAL OF NUTRITION (2020)

Add to Collection

Article Neurosciences

Amyloid-beta impairs insulin signaling by accelerating autophagy-lysosomal degradation of LRP-1 and IR-β in blood-brain barrier endothelial cells in vitro and in 3XTg-AD mice

Chaitanya Chakravarthi Gali, Elham Fanaee-Danesh, Martina Zandl-Lang, Nicole Maria Albrecher, Carmen Tam-Amersdorfer, Anika Stracke, Vinay Sachdev, Florian Reichmann, Yidan Sun, Afrim Avdili, Marielies Reiter, Dagmar Kratky, Peter Holzer, Achim Lass, Karunya K. Kandimalla, Ute Panzenboeck

MOLECULAR AND CELLULAR NEUROSCIENCE (2019)

Add to Collection

Article Multidisciplinary Sciences

Experimental colitis reduces microglial cell activation in the mouse brain without affecting microglial cell numbers

Hoda M. Sroor, Ahmed M. Hassan, Geraldine Zenz, Paulina Valadez-Cosmes, Aitak Farzi, Peter Holzer, Amany El-Sharif, Fatma Al-Zahraa M. Gomaa, Julia Kargl, Florian Reichmann

SCIENTIFIC REPORTS (2019)

Add to Collection

Article Neurosciences

Anhedonia induced by high-fat diet in mice depends on gut microbiota and leptin

Ahmed M. Hassan, Giulia Mancano, Karl Kashofer, Gerhard Liebisch, Aitak Farzi, Geraldine Zenz, Sandrine P. Claus, Peter Holzer

Summary: The study found that the anhedonia-like behavior induced by a high-fat diet in mice depends on the intestinal microbiota and involves the hormone leptin as a signaling molecule.

NUTRITIONAL NEUROSCIENCE (2022)

Add to Collection

Article Multidisciplinary Sciences

Transient receptor potential ankyrin 1 contributes to somatic pain hypersensitivity in experimental colitis

Piyush Jain, Serena Materazzi, Francesco De Logu, Duccio Rossi Degl'Innocenti, Camilla Fusi, Simone Li Puma, Ilaria M. Marone, Elisabetta Coppi, Peter Holzer, Pierangelo Geppetti, Romina Nassini

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Multidisciplinary Sciences

Galanin receptor 3 attenuates inflammation and influences the gut microbiota in an experimental murine colitis model

Susanne M. Brunner, Florian Reichmann, Julia Leitner, Soraya Woelfl, Stefan Bereswill, Aitak Farzi, Anna-Maria Schneider, Eckhard Klieser, Daniel Neureiter, Michael Emberger, Markus M. Heimesaat, Daniel Weghuber, Roland Lang, Peter Holzer, Barbara Kofler

Summary: The neuropeptide galanin and its receptors GAL(2)R and GAL(3)R are involved in immunity and inflammation, with GAL(3)R loss exacerbating colitis in mice. This suggests that GAL(3)R could be a potential therapeutic target for inflammatory bowel disease (IBD).

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Lack of peptide YY signaling in mice disturbs gut microbiome composition in response to high-fat diet

Aitak Farzi, Chi Kin Ip, Felicia Reed, Ronaldo Enriquez, Geraldine Zenz, Marija Durdevic, Lei Zhang, Peter Holzer, Herbert Herzog

Summary: The lack of PYY in mice results in distinct changes in gut microbiome composition, especially under high-fat diet conditions. Pyy-KO mice showed an increased abundance of Bacteroidetes phylum and specific genera within it, indicating a gene-environment interaction between diet and gut microbiome that can impact gut homeostasis.

FASEB JOURNAL (2021)

Add to Collection

Article Cell Biology

Dietary spermidine improves cognitive function

Sabrina Schroeder, Sebastian J. Hofer, Andreas Zimmermann, Raimund Pechlaner, Christopher Dammbrueck, Tobias Pendl, G. Mark Marcello, Viktoria Pogatschnigg, Martina Bergmann, Melanie Mueller, Verena Gschiel, Selena Ristic, Jelena Tadic, Keiko Iwata, Gesa Richter, Aitak Farzi, Muammer Uecal, Ute Schaefer, Michael Poglitsch, Philipp Royer, Ronald Mekis, Marlene Agreiter, Regine C. Toelle, Peter Sotonyi, Johann Willeit, Barbara Mairhofer, Helga Niederkofler, Irmgard Pallhuber, Gregorio Rungger, Herbert Tilg, Michaela Defrancesco, Josef Marksteiner, Frank Sinner, Christoph Magnes, Thomas R. Pieber, Peter Holzer, Guido Kroemer, Didac Carmona-Gutierrez, Luca Scorrano, Joem Dengjel, Tobias Madl, Simon Sedej, Stephan J. Sigrist, Bence Racz, Stefan Kiechl, Tobias Eisenberg, Frank Madeo

Summary: Dietary spermidine has been shown to enhance cognition by affecting mitochondrial and autophagic function in aged mice and fruit flies. These findings suggest the potential role of dietary spermidine in improving cognitive function.

CELL REPORTS (2021)

Add to Collection

Review Physiology

Constipation Caused by Anti-calcitonin Gene-Related Peptide Migraine Therapeutics Explained by Antagonism of Calcitonin Gene-Related Peptide's Motor-Stimulating and Prosecretory Function in the Intestine

Peter Holzer, Ulrike Holzer-Petsche

Summary: The development of small-molecule CGRP receptor antagonists and monoclonal antibodies targeting the CGRP system has revolutionized migraine management. However, constipation has been observed as a major adverse event in patients treated with these therapies. This review article investigates the mechanism behind CGRP inhibition-induced constipation.

FRONTIERS IN PHYSIOLOGY (2022)

Add to Collection

Editorial Material Behavioral Sciences

Gut Signals and Gut Feelings: Science at the Interface of Data and Beliefs

Peter Holzer

FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2022)

Add to Collection

Article Multidisciplinary Sciences

Fibromyalgia-associated hyperalgesia is related to psychopathological alterations but not to gut microbiome changes

Thomas Weber, Eva Tatzl, Karl Kashofer, Magdalena Holter, Slave Trajanoski, Andrea Berghold, Akos Heinemann, Peter Holzer, Michael Karl Herbert

Summary: Fibromyalgia-syndrome (FMS) is a complex disease characterized by chronic widespread pain and additional symptoms. This study found that FMS patients differed from healthy controls in terms of pain parameters and psychological disturbances, but not in the composition and diversity of the fecal microbiome. The contribution of the gut microbiome to the pathophysiology of FMS was considered limited.

PLOS ONE (2022)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.